Stanford Graduate School of Business (USA)
-
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems - Teaching Note
Chess, R; Luthre, JTeaching Note SGSB-E489TN-EEntrepreneurshipInternational healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the United States, where the health-spending share of GDP rose from five percent in 1960 to 17.9 percent in 2011. In Organization for Economic Co-operation and Development (OECD) countries on a...Starting at €0.00
-
Align Technology: Clearing the Way for Digital
Siegel, Robert E; Robinson, PatrickCase SGSB-E686-EEntrepreneurshipAlign Technologies was a leader in disrupting the orthodontist and dental markets with the original development of clear plastic aligners, which allowed for customized solutions to malocclusions, the incorrect alignment of teeth and jaws. Unlike traditional braces, plastic aligners enabled more flexibility and customization by combining digital and physical technologies that were convenient and attractive than other alternatives. As the company b...Starting at €8.20
-
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems
Chess, R; Luthre, JCase SGSB-E489-EEntrepreneurshipInternational healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the United States, where the health-spending share of GDP rose from five percent in 1960 to 17.9 percent in 2011. In Organization for Economic Co-operation and Development (OECD) countries on a...Starting at €8.20
-
Leading Global Innovation at EY - Jeff Wong
Wilkinson, Amy; Robinson, PatrickCase SGSB-E810-EEntrepreneurshipAt EY, Jeff Wong served as chief innovation officer beginning in 2015. In this role, he was responsible for driving innovation and inoculating EY against potential threats to its $45 billion revenue global business. Wong’s role advanced and grew with his success in launching initiatives for EY around artificial intelligence, blockchain, Web3, and automation among others. Through it all, Wong built the Global Innovation team at EY from a $5 millio...Starting at €8.20